PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

Where we at?, page-399

  1. 58 Posts.
    lightbulb Created with Sketch. 4
    How much do they need to see P3 out though?

    This is one of the big grey areas I think which is not good for market speculation. Allot of vague talk about how most of the outgoings have been upfront with setting up the trial, but transparency over what the total cost profile is expected to be (and how its tracking) I think could be what the market needs here.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.